 |
|
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):605-622. Published online 2023 Feb 15 DOI: https://doi.org/10.3350/cmh.2022.0342
|
|
Citations to this article as recorded by
 Effects of Citrus depressa Hayata juice on high-fat diet-induced obesity in HBV transgenic mice
Pei-Yi Chu, Chang-Lu Hsu, Yen-An Lin, Yi-Cheng Pan, Yun-Hao Dai, Ying-Chun Yu, Juan-Cheng Yang, Wen-Lung Ma, Yi-Jinn Lillian Chen, Chia-Lin Lee, Yang-Chang Wu
Heliyon.2024; 10(2): e24438. CrossRef Precision Management of Patients with HBV Infection
Chih-Lin Lin, Jia-Horng Kao
Current Hepatology Reports.2024; 23(1): 22. CrossRef Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Sang Hoon Ahn, Won Kim, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Sun Young Yim, Jin Kyung Park, Soon
Cancers.2024; 16(5): 887. CrossRef Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio, Hie-Won Hann
Cancers.2024; 16(4): 777. CrossRef Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients
Chinmay Bera, Nashla Hamdan-Perez, Keyur Patel
Journal of Clinical Medicine.2024; 13(4): 1046. CrossRef Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort
Jeong-Ju Yoo, Young-Gi Song, Ji Eun Moon, Young Seok Kim, Sang Gyune Kim
Clinical Gastroenterology and Hepatology.2024; 22(9): 1953. CrossRef Research Progress of Pegylated Interferon Therapy for Chronic HBV Infection
巧霞 陈
Advances in Clinical Medicine.2024; 14(03): 1605. CrossRef Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB
Shaowen Jiang, Simin Guo, Yan Huang, Jie Xu, Yi Li, Yilan Zeng, Yuan Guo, Lijuan Ouyang, Chuanwu Zhu, Weifeng Zhao, Qin Zhang, Qing Guo, Haiguang Xin, Qing Xie
Antiviral Research.2024; 226: 105892. CrossRef Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
Qi‐Hang Cao, Hui Liu, Lun‐Jie Yan, Han‐Chao Wang, Zi‐Niu Ding, Xin‐Cheng Mao, Rui‐Zhe Li, Guo‐Qiang Pan, Xiao Zhang, Bao‐Wen Tian, Cheng‐Long Han, Zhao‐Ru Dong, Si‐Yu Tan, Dong‐Xu Wang, Yu‐Chuan Yan, Tao Li
Journal of Gastroenterology and Hepatology.2024; 39(8): 1464. CrossRef Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score
Qi Wang, Shugui Sheng, Yiqi Xiong, Ming Han, Ronghua Jin, Caixia Hu
Frontiers in Immunology.2024;[Epub] CrossRef Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do
Walaa Abdelhamed, Mohamed El-Kassas
Liver Research.2024; 8(2): 83. CrossRef Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B
Ploutarchos Pastras, Evaggelos Zazas, Maria Kalafateli, Ioanna Aggeletopoulou, Efthymios P. Tsounis, Stavros Kanaloupitis, Konstantinos Zisimopoulos, Eirini-Eleni-Konstantina Kottaridou, Aspasia Antonopoulou, Dimosthenis Drakopoulos, Georgia Diamantopoulo
Cancers.2024; 16(14): 2521. CrossRef Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
Clinical and Molecular Hepatology.2024; 30(3): 500. CrossRef Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection
Junjie Chen, Tienan Feng, Qi Xu, Xiaoqi Yu, Yue Han, Demin Yu, Qiming Gong, Yuan Xue, Xinxin Zhang
Journal of Medical Virology.2024;[Epub] CrossRef The unfolded features on the synchronized fashion of gut microbiota and Drynaria rhizome against obesity via integrated pharmacology
Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Min Ju Kim, Dong Joon Kim, Ki-Tae Suk
Food Chemistry.2024; 460: 140616. CrossRef M2BPGi Correlated with Immunological Biomarkers and Further Stratified Recurrence Risk in Patients with Hepatocellular Carcinoma
I-Cheng Lee, Hao-Jan Lei, Lei-Chi Wang, Yi-Chen Yeh, Gar-Yang Chau, Cheng-Yuan Hsia, Shu-Cheng Chou, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang
Liver Cancer.2024; : 1. CrossRef Beta‐caryophyllene attenuates experimental hepatocellular carcinoma through downregulation of oxidative stress and inflammation
Zaved Ahmad, Subodh Kumar Jain, Siddhartha Kumar Mishra
Journal of Biochemical and Molecular Toxicology.2024;[Epub] CrossRef The impact of hepatitis B surface antigen seroconversion on the durability of functional cure induced by pegylated interferon alpha treatment
Wencong Zhang, Jia Chen, Wenjin Sun, Nana Xie, Fangbing Tian, Qiurong Ruan, Jianxin Song
Virology Journal.2024;[Epub] CrossRef Test All for Hepatitis B Virus
Katerina Roma, Zahra Dossaji, Lubaba Haque, Tooba Laeeq, Robert G. Gish, Carol Brosgart
Clinics in Liver Disease.2023; 27(4): 997. CrossRef Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Xuehong Zhang, Sang Hoon Ahn
International Journal of Cancer.2023; 153(8): 1448. CrossRef Evidence-Based Strategies for Micro-elimination of Chronic Hepatitis B Virus Infection
Katerina Roma, Mark Hsu, Adam Khattak, Robert Gish
Current Hepatology Reports.2023; 22(3): 118. CrossRef
|